|
Teva Pharmaceutical Industries Limited - Sales Analysis Snapshot
Business Description
This Report provides a comprehensive Sales & Margin summary analysis for Teva Pharmaceutical Industries Limited Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.
Teva Pharmaceutical Industries Limited. The Group's principal activities are to involve in the development, manufacturing, marketing and distribution of Pharmaceuticals and Active Pharmaceutical Ingredients. The Group operates under two segments: Pharmaceutical and API. Under Pharmaceutical, the Group involves in the development, production, marketing and distribution of drugs in various dosages and forms, in most areas of medicinal treatment and disposable hospital supplies. Under API, the Group involves in the development, production, marketing and distribution of API for the pharmaceutical industry. The Group manufactures solid dosage forms, injectables, liquids, semi-solids and inhalers. The products of the Group include Copaxone and Azilect. The Group operates with 34 dosage pharmaceutical plants in North America, Latin America, Europe, Israel and China. The majority of the Group's sales are in North America and Western Europe. It acquired Barr in 2008.
Not the Report you are looking for? Click here for more browsing options.
Layout and Content of a Typical Report
|
